The Australia biobanking market was valued at USD 1.25 Billion in 2025 and is expected to grow at a CAGR of 3.90%, reaching USD 1.83 Billion by 2035. The market growth is supported by advanced healthcare infrastructure, government-backed research initiatives, and rising adoption of precision medicine. Increasing collaborations between academic institutions and pharmaceutical companies along with growing demand for genomic studies are boosting development. Expanding use of digital health platforms, AI-driven data integration, and personalized medicine research is expected to accelerate market growth in the forecast period.
Base Year
Historical Period
Forecast Period
In June 2023, QUT received a USD 2.92 million grant to establish Australia’s first comprehensive human microbiome biobank, enabling the isolation of thousands of microbial strains, which is expected to accelerate research and significantly drive market growth.
One of the major market trends includes the expansion of biobanks to support post-viral illness research. For instance, in October 2023, the AusME Registry and Biobank in Australia extended to include long COVID, enhancing biosample collection and driving market growth.
The market is experiencing growth driven by key players’ investments in advanced storage, data integration, and research collaborations, enhancing sample accessibility and supporting innovations in personalized medicine and clinical research.
Compound Annual Growth Rate
3.9%
Value in USD Billion
2026-2035
*this image is indicative*
Biobanking plays a crucial role in advancing medical research, precision medicine, and drug development by providing high-quality biological samples that support studies in genomics, personalized therapies, and disease prevention. The market is expanding due to increasing research activities, government support, and rising demand for personalized healthcare solutions. The market is poised to grow at a CAGR of 3.90% during the forecast period of 2026-2035.
Growing Focus on Rare Disease Research to Boost Biobanking Market Demand in Australia
The growing emphasis on rare disease research is a key driver of the market. Biobanks provide critical access to high-quality biological samples and associated clinical data, enabling researchers to develop targeted therapies and advance precision medicine. For example, in June 2025, the Australian Marrow Failure Biobank (AMFB) at Monash University, funded by Maddie Riewoldt’s Vision, recruited its first participant. This disease-specific biobank, integrated with Biobanking Victoria, offers coordinated access to samples linked with the Aplastic Anaemia and Other Bone Marrow Failure Syndromes Registry. Such initiatives are enhancing research capabilities and are expected to significantly support market growth in Australia.
The market is experiencing key trends such as enhancing preservation through living biobanks and driving innovation with genetic biobanking.
Advancing Conservation Through Living Biobanks to Elevate the Market Demand
The emergence of living biobanks aimed at preserving the nation’s unique wildlife biodiversity is a significant trend in the market. In January 2024, the University of Melbourne and Museums Victoria Research Institute initiated efforts to collect and cryogenically preserve live cells from endangered mammals, reptiles, and birds. This innovative approach not only safeguards genetic diversity but also supports research in reproductive technologies and species restoration. By enhancing conservation strategies and enabling advanced scientific studies, living biobanks are expected to drive substantial growth in the Australian biobanking market.
Focus on Genetic Biobanking to Boost Australia Biobanking Market Growth
The market is witnessing a significant trend toward specialized genetic biobanks aimed at advancing personalized therapies. In February 2025, Ear Science Australia launched The Aussie Ear Bank, the nation’s first biobank dedicated to hereditary hearing loss. This facility collects tissue samples linked to genetic hearing disorders and integrates audiometric and genetic data, enabling researchers and clinicians to accelerate gene therapy development. By fostering national and international collaboration, such initiatives are enhancing research capacity, clinical trials, and therapeutic innovation, positioning Australia’s biobanking market for substantial growth in the coming years.
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Type
Market Breakup by Storage Type
Market Breakup by Sample Type
Market Breakup by Ownership
Market Breakup by Application
Market Breakup by End User
Services are Expected to Lead the Market by Type
The market is segmented by type into equipment, consumables, services, and software. Each category plays a vital role, from advanced storage systems and laboratory consumables to digital platforms and specialized service providers. Among these, services are expected to lead the market, supported by rising demand for sample collection, processing, preservation, and data integration. For instance, in July 2025, Australia launched the Australian Marrow Failure Biobank (AMFB) at Monash University, a purpose-built facility integrating biospecimens with national registry data to advance rare disease research. Such initiatives highlight the growing reliance on professional biobanking services to ensure standardization, efficiency, and accessibility, thereby positioning this segment at the forefront of market growth.
The key features of the market report comprise funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Thermo Fisher Scientific Inc. is a global leader in life sciences and plays a pivotal role in the biobanking market with its comprehensive portfolio of products and services. The company provides advanced solutions for biobanking sample collection, preparation, analysis, storage, and transport, supported by cold chain logistics and data management software. Popular offerings such as TSX Series ultra-low temperature freezers, Nunc™ cryogenic tubes, and RNAlater®-ICE solutions ensure sample integrity and efficient workflow management. Through its innovations, Thermo Fisher enables researchers and biobanks to preserve biospecimens, enhance data sharing, and accelerate discoveries in healthcare and life sciences.
PHC Holdings Corporation, a leading provider of medical and laboratory equipment, plays a significant role in the global biobanking market through its advanced PHCbi ultra-low temperature (ULT) freezers. These freezers were selected for the LifeLines project, a large-scale genetic study, due to their superior temperature stability, energy efficiency, and reliability. By ensuring secure long-term storage of millions of biological samples, PHC supports critical research in chronic diseases and healthy aging.
Merck KGaA, a leading global science and technology company, plays a significant role in the biobanking and life sciences market through its advanced microbiology and biocontamination monitoring solutions. Its portfolio includes sterility and bioburden testing services, environmental monitoring systems such as the MAS-100® series, and rapid microbial detection technologies like the Milliflex® Quantum and Milliflex® Rapid System 2.0. These innovations support pharmaceutical, biopharma, and diagnostic research, strengthening quality control and sample integrity essential for biobanking applications.
Avantor, Inc. is a global leader in life sciences, providing essential products, services, and digital solutions that support biobanking, biopharma, and advanced research. The company’s portfolio includes high-quality solvents, safety-coated DURAN® bottles, and innovative open and closed systems designed for secure sample handling and storage. Avantor plays a key role in the biobanking market by enabling reliable preservation and processing of biological materials critical for research and clinical applications.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include Qiagen N.V., Tecan Group Ltd., Becton, Dickinson and Company (BD), Cryoport Inc., Azenta Inc., Greiner AG, Australia Health Biobank, and Phenomics Australia.
Upto 15% Off
USD
$1999 $1799
$3099 $2789
$4599 $3909
$5999 $5099
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Storage Type |
|
| Breakup by Sample Type |
|
| Breakup by Ownership |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 1,999
USD 1,799
tax inclusive*
Single User License
One User
USD 3,099
USD 2,789
tax inclusive*
Five User License
Five User
USD 4,599
USD 3,909
tax inclusive*
Corporate License
Unlimited Users
USD 5,999
USD 5,099
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share